Rafael López López

Suggest Changes
Learn More
This study aims to determine the incidence of nausea and vomiting (CINV) after moderately emetogenic chemotherapy (MEC), under medical practice conditions and the accuracy with which physicians(More)
BACKGROUND HER2-positive breast cancer consists of four intrinsic molecular subtypes-luminal A, luminal B, HER2-enriched, and basal-like-and a normal-like subtype, with the HER2-enriched subtype(More)
3567 Background: X has superior efficacy and improved safety compared to bolus 5-FU/LV in 1st line MCRC and preserves its safety advantage in pts >65 in the adjuvant setting. We investigated its use(More)